Stoke Therapeutics Inc (STOK)
14.03
-0.10
(-0.71%)
USD |
NASDAQ |
May 16, 16:00
14.03
0.00 (0.00%)
After-Hours: 20:00
Stoke Therapeutics Free Cash Flow (Quarterly): -24.58M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -24.58M |
| December 31, 2023 | -20.88M |
| September 30, 2023 | -17.64M |
| June 30, 2023 | -22.64M |
| March 31, 2023 | -21.52M |
| December 31, 2022 | -22.78M |
| September 30, 2022 | -24.09M |
| June 30, 2022 | -20.61M |
| March 31, 2022 | 31.65M |
| December 31, 2021 | -16.46M |
| September 30, 2021 | -14.96M |
| June 30, 2021 | -16.35M |
| March 31, 2021 | -20.34M |
| Date | Value |
|---|---|
| December 31, 2020 | -11.02M |
| September 30, 2020 | -11.14M |
| June 30, 2020 | -9.727M |
| March 31, 2020 | -11.38M |
| December 31, 2019 | -10.77M |
| September 30, 2019 | -8.631M |
| June 30, 2019 | -6.666M |
| March 31, 2019 | -6.624M |
| December 31, 2018 | -3.608M |
| September 30, 2018 | -3.557M |
| June 30, 2018 | -2.719M |
| March 31, 2018 | -2.015M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-24.58M
Minimum
Mar 2024
31.65M
Maximum
Mar 2022
-14.03M
Average
-16.41M
Median
Free Cash Flow (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | -2.003M |
| iBio Inc | -4.706M |
| Actinium Pharmaceuticals Inc | -7.385M |
| Lixte Biotechnology Holdings Inc | -0.7892M |
| Fate Therapeutics Inc | -33.44M |